Please login to the form below
Aimvog
This page shows the latest Aimvog news and features for those working in and with pharma, biotech and healthcare.
CGRP migraine drugs need prior approval for use, recommends ICER
Suggests clinicians should confirm that patients have tried other therapies prior to using CGRP inhibitors
Latest news
-
Novartis, Amgen set low price for first CGRP migraine drug
Aimovig has a list price of $6,900 per year
-
Allergan’s oral migraine drug closer to US filing
New data keeps Allergan ahead of rival Biohaven
More from news
Approximately 3 fully matching, plus 0 partially matching documents found.
Featured jobs
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Associate Medical Director
-
Salary TBC
-
Account Director - Digital
-
Great salary and benefits
-
Scientific Team Lead
-
Competitive Salary
-
Associate Medical Director
-
Highly Competitive
- Director Healthcare PR Communications
-
Salary TBC
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
- Account Manager, Healthcare Advertising
-
Salary TBC
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Experienced Editor, London, Medical Communications
-
Competitive package
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Account Director
-
Negotiable
-
Scientific Director
-
Highly Competitive Salary &Benefits
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
- Account Director – Global Healthcare PR
-
Salary TBC
Subscribe to our email news alerts
- Shire’s angioedema drug Takhzyro recommended in Europe
- Cuttsy+Cuttsy launch their latest patient e-book
- McCann Health London launch Urban Eye Test
- Encouraging data for GenSight’s blinding retinal disease gene therapy
- Keytruda hits survival targets in first-line kidney cancer
- UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen
PMHub
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...
Latest intelligence
- Retaining reader value in plain language summaries of clinical studies
- Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe's leading hub for life sciences innovation...
Quick links
Infographics
